NT_1170x120_1-11-18

Mapi Pharma Ltd.

Mylan to partner with Mapi Pharma on new MS drug

Mylan to partner with Mapi Pharma on new MS drug

HERTFORDSHIRE, England and PITTSBURGH and NESS ZIONA, Israel — Mylan N.V. and Mapi Pharma Ltd. announced that the two companies will team on the development and commercialization of GA Depot, a long-acting Glatiramer Acetate product. Mylan is acquiring global marketing rights to the product. GA Depot is a proposed once-monthly injection for the treatment of